Dectrocel

Dectrocel is a legitimate seed-stage HealthTech company based in Lucknow, India, developing AI diagnostics (DecXpert) for tuberculosis and cancer. While the submission contained exaggerated claims ('most people have used my product') and confusing financial data (listing 40M INR funding as market cap), external verification confirms regulatory approval (CDSCO), recent funding (~$480k/4Cr INR), and pilot traction (~10,000 screenings). The project has high real-world utility and technical merit, but the PoU score reflects its current early-stage traction (<50k users) and poor submission quality.